MACM
March Altus Capital Management Portfolio holdings
AUM
$16M
1-Year Return
18.92%
This Quarter Return
-11.58%
1 Year Return
+18.92%
3 Year Return
+153.93%
5 Year Return
–
10 Year Return
–
AUM
$9.67M
AUM Growth
-$1.21M
(-11%)
Cap. Flow
-$2.58M
Cap. Flow
% of AUM
-26.72%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
11
New
1
Increased
1
Reduced
3
Closed
2
Top Buys
| 1 |
Eli Lilly
LLY
|
+$1.29M |
| 2 |
Align Technology
ALGN
|
+$390K |
Top Sells
| 1 |
Edwards Lifesciences
EW
|
+$1.84M |
| 2 |
Incyte
INCY
|
+$1.6M |
| 3 |
AERI
Aerie Pharmaceuticals, Inc.
AERI
|
+$364K |
| 4 |
Acadia Pharmaceuticals
ACAD
|
+$231K |
| 5 |
Regeneron Pharmaceuticals
REGN
|
+$225K |
Sector Composition
| 1 | Healthcare | 80.49% |
| 2 | Industrials | 7.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Eli Lilly
LLY
$677B
| $1.93M | 19.98% |
26,810
+17,912
| +201% | +$1.29M |
|
|
2
Edwards Lifesciences
EW
$45.5B
| $1.54M | 15.92% |
52,329
-62,637
| -54% | -$1.84M |
|
3
DexCom
DXCM
$29.9B
| $1.29M | 13.38% |
76,184
| – | – |
|
|
PETX
4
DELISTED
Aratana Therapeutics, Inc.
PETX
| $1.21M | 12.48% |
218,515
| – | – |
|
|
ALXN
5
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $1.2M | 12.38% |
8,599
| – | – |
|
|
6
Regeneron Pharmaceuticals
REGN
$59.4B
| $826K | 8.55% |
2,291
-625
| -21% | -$225K |
|
|
ATHN
7
DELISTED
Athenahealth, Inc.
ATHN
| $680K | 7.04% |
4,900
| – | – |
|
|
8
Acadia Pharmaceuticals
ACAD
$3.98B
| $603K | 6.24% |
21,552
-8,249
| -28% | -$231K |
|
|
9
Align Technology
ALGN
$9.54B
| $390K | 4.04% |
+5,366
| New | +$390K |
|
|
10
Incyte
INCY
$16.2B
| – | – |
-14,756
| Closed | -$1.6M |
|
|
AERI
11
DELISTED
Aerie Pharmaceuticals, Inc.
AERI
| – | – |
-14,962
| Closed | -$364K |
|